These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1440100)

  • 1. [Chronic myeloid leukemia with progression to polycythemia vera].
    Campo MC; Fortún A; Travieso J
    Sangre (Barc); 1992 Jun; 37(3):207-8. PubMed ID: 1440100
    [No Abstract]   [Full Text] [Related]  

  • 2. [The progression of polycythemia vera to chronic myeloid leukemia].
    Jantunen E; Nousiainen T
    Duodecim; 1991; 107(8):641-4. PubMed ID: 1364919
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypocholesterolemia and other lipoprotein disorders in myelofibrosis].
    Kiss A; Telek B; Rák K
    Orv Hetil; 1994 Nov; 135(48):2643-6. PubMed ID: 7808738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCR-ABL1- positive chronic myeloid leukemia with erythrocytosis presenting as polycythemia vera: a case report.
    Cornea MI; Levrat E; Pugin P; Betticher DC
    J Med Case Rep; 2015 Apr; 9():30. PubMed ID: 26187587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medullary fibrosis and splenic erythroblastosis in chronic myeloid leukemia].
    Tanzer J; Najean Y; Jcquillat C; Ripault J; Chome J
    Nouv Rev Fr Hematol; 1967; 7(5):801-8. PubMed ID: 4230115
    [No Abstract]   [Full Text] [Related]  

  • 9. Polycythemia vera terminating in myeloblastic transformation and myelofibrosis with tumor formation.
    Yonemitsu H; Okuda K; Niwa Y; Kondo Y
    Nihon Ketsueki Gakkai Zasshi; 1983 Jul; 46(4):822-6. PubMed ID: 6579811
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
    Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
    Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib and ruxolitinib association: first experience in two patients.
    Iurlo A; Gianelli U; Rapezzi D; Cattaneo D; Fermo E; Binda F; Santambrogio E; Bucelli C; Cortelezzi A
    Haematologica; 2014 Jun; 99(6):e76-7. PubMed ID: 24633869
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vaquez-Osler disease?].
    de Vries SI
    Ned Tijdschr Geneeskd; 1968 Mar; 112(13):596-8. PubMed ID: 5243326
    [No Abstract]   [Full Text] [Related]  

  • 13. MYELOPROLIFERATIVE SYNDROME; EVALUATION OF MYELOSCLEROSIS AND CHRONIC MYELOGENOUS LEUKEMIA TO POLYCYTHEMIA VERA.
    LOPAS H; JOSEPHSON AM
    Arch Intern Med; 1964 Dec; 114():754-9. PubMed ID: 14211587
    [No Abstract]   [Full Text] [Related]  

  • 14. A myeloproliferative disorder may hide another one.
    Laibe S; Tadrist Z; Arnoulet C; Sainty D; Mozziconacci MJ
    Leuk Res; 2009 Aug; 33(8):1133-6. PubMed ID: 19250672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [30 cases of myeloid metaplasia and 5 cases of acute leukemia in a group of 200 cases of polycythemia vera].
    Nicoară S; Butoianu E; Ciocoiu A; Coliţă A; Grigoriu G; Vîlcu A; Ursea C; Dosius L; Niculescu R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):261-6. PubMed ID: 6140721
    [No Abstract]   [Full Text] [Related]  

  • 16. Inter-relationship between polycythaemia vera, leukaemia and myeloid metaplasia.
    Modan B
    Clin Haematol; 1975 Jun; 4(2):427-39. PubMed ID: 1102196
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ENERGY METABOLISM OF HUMAN THROMBOCYTES UNDER NORMAL CONDITIONS AND IN POLYCYTHEMIA AND CHRONIC MYELOSIS].
    EGOROVA VA; BLINOVA AI; SEITS IF
    Vopr Med Khim; 1965; 11():35-41. PubMed ID: 14339546
    [No Abstract]   [Full Text] [Related]  

  • 19. Retinopathy secondary to anemia from myeloid metaplasia in polycythemia vera.
    Blood AM; Lowenthal EA; Nowakowski RW
    J Am Optom Assoc; 1997 Nov; 68(11):734-8. PubMed ID: 9409109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.